康辰药业：控股股东刘建华已减持3.00%股份

Core Points - The controlling shareholder of Kangchen Pharmaceutical, Liu Jianhua, has reduced his stake in the company by selling 4,780,600 shares, which accounts for 3% of the total share capital [1] - The reduction plan was executed from September 30, 2025, to October 31, 2025, with a share price range of 42.80 to 53.44 yuan per share, resulting in a total amount of 187 million yuan [1] - Following the share reduction, Liu Jianhua's ownership percentage decreased from 31.87% to 28.87% [1]